Insider Transactions in Q3 2022 at Arrowhead Pharmaceuticals, Inc. (ARWR)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2022
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
40,624
-0.58%
|
$1,218,720
$30.99 P/Share
|
|
Jul 08
2022
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
551,197
-13.58%
|
-
|
|
Jul 07
2022
|
Christopher Richard Anzalone Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,501
+0.06%
|
$35,014
$14.54 P/Share
|